Karl‐Ulrich Bühring

Author

Karl‐Ulrich Bühring

Also Known As

K BUHRING, K. U. Buhring, K. U. Bühring, Karl-Ulrich Bühring, Karl‐Ulrich Bühring

Publications

286

Citations

H-Index

Concepts

All Affiliations

Karl‐Ulrich Bühring is an author at Merck (Germany) specializing in pharmacology, medicine, and toxicology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	211
2	Biochemistry	3	3	123
3	Metabolism	2	2	102
4	Natural Sciences	1	1	21
5	Chemical Biology	1	1	21

Karl‐Ulrich Bühring

Publications

282

Citations

H-Index

Page 1

	Year	Citations
Basic Pharmacokinetics of Bisoprolol, a New Highly Beta<sub>1</sub>‐selective Adrenoceptor Antagonist Götz Leopold, J. Pabst, W Ungethüm, The Journal of Clinical Pharmacology Unchanged DrugMolecular PharmacologyPharmacological StudyBasic PharmacokineticsMedicine	1986	88
Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer’s Disease—Studies on Relation to Effective Target Occupancy Torsten Hoffmann, Antje Meyer, Ulrich Heiser, Journal of Pharmacology and Experimental Therapeutics	2017	71
Metabolism of praziquantel in man Karl‐Ulrich Bühring, H. W. Diekmann, H. Müller, European Journal of Drug Metabolism and Pharmacokinetics BiochemistryMedicineSecondary MetaboliteClinical PharmacologyToxicology	1978	58
The fate of praziquantel in the organism III. Metabolism in rat, beagle dog and rhesus monkey H. W. Diekmann, Karl‐Ulrich Bühring European Journal of Drug Metabolism and Pharmacokinetics Organism IiiBiochemistryMedicinePhysiologyToxicology	1976	44
Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa Werner W. K. R. Mederski, Bertram Cezanne, Christoph van Amsterdam, Bioorganic & Medicinal Chemistry Letters ThrombosisMedicinal ChemistryBiochemistryMedicineNatural Sciences	2004	21

Page 1